公开(公告)号：US07256742B2

公开(公告)日：2007-08-14

申请号：US11199079

申请日：2005-08-09

Applicant: Bin-Hung Chen ,  Chih-Ming Chen

Inventor： Bin-Hung Chen ,  Chih-Ming Chen

IPC: H01Q1/24 ,  H01Q1/38

CPC classification number: H01Q1/243 ,  Y10T29/49016 ,  Y10T156/10

Abstract: A flexible antenna apparatus and a manufacturing method thereof are provided for wireless communication devices. The flexible antenna has a metal layer with an adhesive layer pasted onto the back surface of the metal layer, so that it can be directly pasted onto the housing of the wireless communication device. On another side of the metal layer, there is a transparent protective layer and the metal layer reserves a zone without the transparent protective layer for electrically coupling to the electrical substrate of the wireless communication device. The present flexible antenna apparatus reduces the developing time and cost of the device and the manufacturing process more convenient. The flexible antenna apparatus is suitable for all wireless communication devices and increases the flexibility of the manufacturing process by adding a holder having at least one plastic pin, or a pin.

Abstract translation: 为无线通信装置提供柔性天线装置及其制造方法。 柔性天线具有金属层，该金属层粘附在金属层的背面上，从而可将其直接粘贴到无线通信设备的外壳上。 在金属层的另一侧，存在透明保护层，金属层保留没有透明保护层的区域，用于电耦合到无线通信设备的电气基板。 本发明的柔性天线装置减少了设备的开发时间和成本，并且制造过程更加方便。 柔性天线装置适用于所有无线通信装置，并通过添加具有至少一个塑料针或针的保持器来增加制造过程的灵活性。

公开(公告)号：US20070160671A1

公开(公告)日：2007-07-12

申请号：US11724931

申请日：2007-03-16

Applicant: Xiu-Xiu Cheng ,  Chih-Ming Chen ,  Steve Jan ,  Dacheng Tian

Inventor： Xiu-Xiu Cheng ,  Chih-Ming Chen ,  Steve Jan ,  Dacheng Tian

IPC: A61K9/14 ,  A61K31/155

CPC classification number: A61K9/2054 ,  A61K9/1611 ,  A61K9/1623 ,  A61K9/1635 ,  A61K9/1652 ,  A61K31/155

Abstract: In certain embodiments, the invention is directed to a pharmaceutical dosage form consisting essentially of a single phase matrix comprising metformin or a pharmaceutically acceptable salt thereof and at least one controlled release excipient; said dosage form providing a mean Tmax of metformin from about 3 to about 12 hours after administration to human patients.

Abstract translation: 在某些实施方案中，本发明涉及基本上由包含二甲双胍或其药学上可接受的盐和至少一种控制释放赋形剂的单相基质组成的药物剂型; 所述剂型在给予人类患者后约3至约12小时提供二甲双胍的平均T max最大值。

公开(公告)号：US20060245952A1

公开(公告)日：2006-11-02

申请号：US11108637

申请日：2005-04-19

Applicant: Chih-Ming Chen

Inventor： Chih-Ming Chen

IPC: F04B35/04

CPC classification number: F04B35/04 ,  F04B35/01 ,  F04B39/0027 ,  F04B39/066 ,  F04B39/12

Abstract: An improvement in the structure for an air pump, and in particular, an air pump, which is sealed to isolate the noise of operation, and the motor body and the cylinder, can be rapidly cooled. The improved air pump employs the circulation of air to the motor so as to lead the external air to the cylinders of the pump so as to keep the motor body and the cylinder at a cooler temperature. This allows the motor to work effectively and efficiently.

Abstract translation: 可以快速冷却用于空气泵的结构的改进，特别是密封以隔离操作噪声的气泵和电动机主体和气缸。 改进的空气泵采用向电动机循环空气，以将外部空气引导到泵的气缸，以使电动机主体和气缸保持在较冷的温度。 这使得电机能够有效和高效地工作。

公开(公告)号：US07093609B2

公开(公告)日：2006-08-22

申请号：US10856870

申请日：2004-06-01

Applicant: Chih-Ming Chen

Inventor： Chih-Ming Chen

IPC: F01K15/20

CPC classification number: F04B33/005 ,  B60S5/043 ,  Y10T137/3584 ,  Y10T137/3724

Abstract: An air inflation tube of a mini-size air pump is disclosed. The air inflation tube of the air pump has a dual direction air inflation capability, that is, inflation and deflation, and the pressure releasing and air pumping are done by the same tubular body to solve the problem of excessive tire pressure without removing the air inflation tube.

Abstract translation: 公开了一种小尺寸空气泵的空气充气管。 空气泵的空气充气管具有双向空气充气能力，即膨胀和放气，并且压力释放和空气泵送由相同的管体来完成，以解决过度的轮胎压力的问题而不去除空气膨胀 管。

公开(公告)号：US20060141035A1

公开(公告)日：2006-06-29

申请号：US11355335

申请日：2006-02-16

Applicant: Chih-Ming Chen ,  Joseph Chou ,  David Wong

Inventor： Chih-Ming Chen ,  Joseph Chou ,  David Wong

IPC: A61K9/22

CPC classification number: A61K9/0004 ,  A61K9/2018 ,  A61K9/2031 ,  A61K9/2886 ,  A61K31/22 ,  A61K31/366

Abstract: Controlled release oral solid dosage form for the reduction of serum cholesterol levels in humans include a drug comprising an alkyl ester of hydroxy substituted naphthalenes (e.g., lovastatin) and a controlled release carrier, such that the dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at about 10 to about 32 hours after oral administration on a once-a-day basis to human patients. The dosage form provides a therapeutically effective reduction in serum cholesterol levels. Methods of reducing serum cholesterol levels in humans are also disclosed.

Abstract translation: 用于降低人体血清胆固醇水平的控释口服固体剂型包括包含羟基取代萘的烷基酯（例如洛伐他汀）和控释载体的药物，使得该剂型提供了最大血浆浓度的平均时间 在每天一次的基础上向人类患者口服给药后约10至约32小时发生的药物（T max max）。 剂型提供治疗有效的降低血清胆固醇水平。 还公开了降低人体血清胆固醇水平的方法。

公开(公告)号：US20060008523A1

公开(公告)日：2006-01-12

申请号：US11224784

申请日：2005-09-13

Applicant: Chih-Ming Chen ,  Xiu-Xiu Cheng ,  Steve Jan ,  Joseph Chou

Inventor： Chih-Ming Chen ,  Xiu-Xiu Cheng ,  Steve Jan ,  Joseph Chou

IPC: A61K9/22

CPC classification number: A61K31/155 ,  A61K9/0004 ,  A61K9/2027

Abstract: A composition for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at 5.5 to 7.5 hours after oral administration on a once-a-day basis to human patients. Preferably, the dose of drug is administered at dinnertime to a patient in the fed state.

公开(公告)号：US20050276850A1

公开(公告)日：2005-12-15

申请号：US10868286

申请日：2004-06-15

Applicant: Nilobon Podhipleux ,  Xiu Cheng ,  Unchalee Lodin ,  Chih-Ming Chen ,  Avinash Nangia ,  Dacheng Tian

Inventor： Nilobon Podhipleux ,  Xiu Cheng ,  Unchalee Lodin ,  Chih-Ming Chen ,  Avinash Nangia ,  Dacheng Tian

IPC: A61K9/16 ,  A61K9/20 ,  A61K9/22 ,  A61K9/28 ,  A61K31/19

CPC classification number: A61K9/2072 ,  A61K9/1652 ,  A61K9/2866 ,  A61K31/19

Abstract: Disclosed is a controlled release formulation comprising valproic acid, pharmaceutically acceptable salt thereof, amide thereof, or derivative thereof.

Abstract translation: 公开了包含丙戊酸，其药学上可接受的盐，其酰胺或其衍生物的控释制剂。

公开(公告)号：US06932259B2

公开(公告)日：2005-08-23

申请号：US10782913

申请日：2004-02-23

Applicant: Kuei-Jung Chen ,  Meng-Chun Chen ,  Chih-Ming Chen ,  Chih-Yi Lai

Inventor： Kuei-Jung Chen ,  Meng-Chun Chen ,  Chih-Ming Chen ,  Chih-Yi Lai

IPC: B26F3/00 ,  B26F3/02 ,  H01L21/00

CPC classification number: H01L21/67092 ,  B26F3/002 ,  Y10T225/325 ,  Y10T225/371 ,  Y10T225/379 ,  Y10T225/386

Abstract: A brittle material breaking apparatus using a lifting mechanism to lift/lower a carrier wherein the lifting mechanism is controlled to lift the carrier for holding the brittle material for breaking, and then to lower the carrier from the brittle material to a distance for enabling the brittle material to be shifted to a next scribe line for further breaking, preventing the occurrence of friction between the brittle material and the carrier and the production of static electricity and micro particles and, improving the breaking quality. The brittle material breaking apparatus further includes a stroke fine adjustment mechanism adapted to adjust the stroke of the breaking-cutter relative to the brittle material.

公开(公告)号：US20050064293A1

公开(公告)日：2005-03-24

申请号：US10668092

申请日：2003-09-19

Applicant: Chih-Hung Shen ,  Shun-Ming Huang ,  Chih-Ming Chen ,  Chih-Chang Lee

Inventor： Chih-Hung Shen ,  Shun-Ming Huang ,  Chih-Ming Chen ,  Chih-Chang Lee

IPC: H01M2/02 ,  H01M6/10 ,  H01M10/052 ,  H01M10/0565 ,  H01M10/0587 ,  H01M10/36 ,  H01M10/40

CPC classification number: H01M10/052 ,  H01M2/0275 ,  H01M2/0285 ,  H01M10/0565 ,  H01M10/0587 ,  H01M2300/0085 ,  Y10T29/4911

Abstract: A mixture of an electrolyte, a first oligomer and an initiating agent is emulsion polymerized to form a precursor solution with a micro void structure for the gel-type electrolyte. A current available jelly-roll is put into an aluminum foil packet, and the precursor solution is then injected into the packet, which is then sealed and baked so that a highly conductive gel-type electrolyte is disposed inside and outside the jelly-roll. The lithium battery with the gel-type electrolyte is very stiff, reliable, and free from expansion and electrolyte leakage.

Abstract translation: 电解质，第一低聚物和引发剂的混合物被乳液聚合以形成具有用于凝胶型电解质的微孔结构的前体溶液。 将当前可用的果冻卷放入铝箔包装袋中，然后将前体溶液注入包装中，然后将其密封并烘烤，使得在胶卷内部和外部设置高导电性凝胶型电解质。 具有凝胶型电解质的锂电池非常硬，可靠，无膨胀和电解液泄漏。

公开(公告)号：US06790459B1

公开(公告)日：2004-09-14

申请号：US09705625

申请日：2000-11-03

Applicant: Xiu Xiu Cheng ,  Chih-Ming Chen ,  Steve Jan ,  Joseph Chou

Inventor： Xiu Xiu Cheng ,  Chih-Ming Chen ,  Steve Jan ,  Joseph Chou

IPC: A61K914

CPC classification number: A61K9/0004 ,  A61K9/2866 ,  A61K31/155

Abstract: A method for treating patients having non-insulin-dependent diabetes mellitus (NIDDM) by administering a controlled release oral solid dosage form containing preferably a biguanide drug such as metformin, on a once-a-day basis. The dosage form provides a mean time to maximum plasma concentration (Tmax) of the drug which occurs at a 5.5 to 7.5 hours after oral administration on a once-a-day basis to human patients. Preferably, the dose of drug is administered at dinnertime to a patient in the fed state.

Abstract translation: 一种通过每天一次施用含有优选双胍类药物如二甲双胍的控释口服固体剂型来治疗患有非胰岛素依赖性糖尿病（NIDDM）的患者的方法。 该剂型提供了在每天一次给予人类患者的口服给药后5.5至7.5小时时药物的最大血药浓度（Tmax）的平均时间。 优选地，在晚餐时间向给喂状态的患者施用药物剂量。